SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-017698
Filing Date
2020-04-21
Accepted
2020-04-21 16:19:29
Documents
15
Period of Report
2020-06-04
Effectiveness Date
2020-04-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A srpt-def14a_20200604.htm DEF 14A 2541579
2 GRAPHIC gmmpklfjqvbs000008.jpg GRAPHIC 11306
3 GRAPHIC gmmpklfjqvbs000005.jpg GRAPHIC 3818
4 GRAPHIC gmmpklfjqvbs000004.jpg GRAPHIC 2174
5 GRAPHIC gmmpklfjqvbs000011.jpg GRAPHIC 12000
6 GRAPHIC gmmpklfjqvbs000003.jpg GRAPHIC 3818
7 GRAPHIC gmmpklfjqvbs000002.jpg GRAPHIC 2084
8 GRAPHIC gmmpklfjqvbs000009.jpg GRAPHIC 11419
9 GRAPHIC gmmpklfjqvbs000001.jpg GRAPHIC 3818
10 GRAPHIC gmmpklfjqvbs000006.jpg GRAPHIC 22639
11 GRAPHIC gmmpklfjqvbs000014.jpg GRAPHIC 71394
12 GRAPHIC gmmpklfjqvbs000007.jpg GRAPHIC 9640
13 GRAPHIC gmmpklfjqvbs000012.jpg GRAPHIC 2063
14 GRAPHIC gmmpklfjqvbs000013.jpg GRAPHIC 74294
15 GRAPHIC gmmpklfjqvbs000010.jpg GRAPHIC 82606
  Complete submission text file 0001564590-20-017698.txt   2976201
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14895 | Film No.: 20805370
SIC: 2834 Pharmaceutical Preparations